Xconomy | Boston - Business + Technology in the Exponential Economy

Related Posts

Kleanthis’s first post…

Kleanthis Xanthopoulos 10/3/08

…is coming soon.

Kleanthis G. Xanthopoulos, Ph.D. is the president and CEO of Regulus Therapeutics, a company developing drugs based on microRNA technology.

Comments | Reprints | Share:   Retweet Facebook Email

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.